Search

everythinglearnresearchcommunity

for

Search:↓

NGF-modified hair follicle stem cells may help treat Alzheimer's by improving brain function and reducing harmful proteins.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

Keratin 15 affects cell behavior and characteristics in skin cells.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

The research shows how certain drug molecules form stable structures with polymers, which could help create new drug forms.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Better standardization and transparency in statistical reporting are needed to improve hair care research quality.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Disease-specific tools better assess quality of life in alopecia areata patients.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Combining different drugs can improve hair loss treatment.